Verification of Underlying Genetic Cause in a Cohort of Russian Patients with Familial Hypercholesterolemia Using Targeted Next Generation Sequencing

Russian patients with familial hypercholesterolemia (FH) were screened for pathogenic mutations using targeted next generation sequencing. Genetic testing was performed in 52 probands with definite or probable FH based on the Dutch lipid clinic network criteria (DLCN score ≥ 6). Blood samples were s...

Full description

Bibliographic Details
Main Authors: Anna E. Semenova, Igor V. Sergienko, Diego García-Giustiniani, Lorenzo Monserrat, Anna B. Popova, Diana N. Nozadze, Marat V. Ezhov
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/7/2/16
_version_ 1797568039391068160
author Anna E. Semenova
Igor V. Sergienko
Diego García-Giustiniani
Lorenzo Monserrat
Anna B. Popova
Diana N. Nozadze
Marat V. Ezhov
author_facet Anna E. Semenova
Igor V. Sergienko
Diego García-Giustiniani
Lorenzo Monserrat
Anna B. Popova
Diana N. Nozadze
Marat V. Ezhov
author_sort Anna E. Semenova
collection DOAJ
description Russian patients with familial hypercholesterolemia (FH) were screened for pathogenic mutations using targeted next generation sequencing. Genetic testing was performed in 52 probands with definite or probable FH based on the Dutch lipid clinic network criteria (DLCN score ≥ 6). Blood samples were studied by massive parallel sequencing (Illumina HiSeq 1500 platform) using a custom capture library related to dyslipidemia and premature atherosclerosis. Mutations considered to be responsible for monogenic FH were identified in 48% of the probands: 24 with mutations in the <i>LDLR</i> gene and two with a mutation in the <i>APOB</i> gene. There were 22 pathogenic/likely pathogenic mutations in <i>LDLR</i>, eight of which have not been previously described in the literature. Four patients with a clinical picture of homozygous FH had two heterozygous <i>LDLR</i> mutations. Although mutation-negative patients had highly elevated total cholesterol and low-density lipoprotein cholesterol levels, only half of them had a family history of hypercholesterolemia. With respect to heterozygous FH, mutation-positive patients had higher maximum total cholesterol levels (<i>p</i> = 0.01), more severe carotid atherosclerotic lesions, and a higher percentage of premature peripheral artery disease (<i>p</i> = 0.03) than mutation-negative ones. However, the number of patients who suffered from myocardial infarction was similar between the two groups.
first_indexed 2024-03-10T19:49:44Z
format Article
id doaj.art-81f7dfdd74384bed81cfeb339cd78bd4
institution Directory Open Access Journal
issn 2308-3425
language English
last_indexed 2024-03-10T19:49:44Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Journal of Cardiovascular Development and Disease
spelling doaj.art-81f7dfdd74384bed81cfeb339cd78bd42023-11-20T00:27:36ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252020-05-01721610.3390/jcdd7020016Verification of Underlying Genetic Cause in a Cohort of Russian Patients with Familial Hypercholesterolemia Using Targeted Next Generation SequencingAnna E. Semenova0Igor V. Sergienko1Diego García-Giustiniani2Lorenzo Monserrat3Anna B. Popova4Diana N. Nozadze5Marat V. Ezhov6National Medical Research Center of Cardiology, 121552 Moscow, RussiaNational Medical Research Center of Cardiology, 121552 Moscow, RussiaHealth in Code SL, Clinical Department, 15006 A Coruña, SpainHealth in Code SL, Clinical Department, 15006 A Coruña, SpainNational Medical Research Center of Cardiology, 121552 Moscow, RussiaNational Medical Research Center of Cardiology, 121552 Moscow, RussiaNational Medical Research Center of Cardiology, 121552 Moscow, RussiaRussian patients with familial hypercholesterolemia (FH) were screened for pathogenic mutations using targeted next generation sequencing. Genetic testing was performed in 52 probands with definite or probable FH based on the Dutch lipid clinic network criteria (DLCN score ≥ 6). Blood samples were studied by massive parallel sequencing (Illumina HiSeq 1500 platform) using a custom capture library related to dyslipidemia and premature atherosclerosis. Mutations considered to be responsible for monogenic FH were identified in 48% of the probands: 24 with mutations in the <i>LDLR</i> gene and two with a mutation in the <i>APOB</i> gene. There were 22 pathogenic/likely pathogenic mutations in <i>LDLR</i>, eight of which have not been previously described in the literature. Four patients with a clinical picture of homozygous FH had two heterozygous <i>LDLR</i> mutations. Although mutation-negative patients had highly elevated total cholesterol and low-density lipoprotein cholesterol levels, only half of them had a family history of hypercholesterolemia. With respect to heterozygous FH, mutation-positive patients had higher maximum total cholesterol levels (<i>p</i> = 0.01), more severe carotid atherosclerotic lesions, and a higher percentage of premature peripheral artery disease (<i>p</i> = 0.03) than mutation-negative ones. However, the number of patients who suffered from myocardial infarction was similar between the two groups.https://www.mdpi.com/2308-3425/7/2/16familial hypercholesterolemianext generation sequencingLDLRDutch lipid clinic network criteriacardiovascular risk
spellingShingle Anna E. Semenova
Igor V. Sergienko
Diego García-Giustiniani
Lorenzo Monserrat
Anna B. Popova
Diana N. Nozadze
Marat V. Ezhov
Verification of Underlying Genetic Cause in a Cohort of Russian Patients with Familial Hypercholesterolemia Using Targeted Next Generation Sequencing
Journal of Cardiovascular Development and Disease
familial hypercholesterolemia
next generation sequencing
LDLR
Dutch lipid clinic network criteria
cardiovascular risk
title Verification of Underlying Genetic Cause in a Cohort of Russian Patients with Familial Hypercholesterolemia Using Targeted Next Generation Sequencing
title_full Verification of Underlying Genetic Cause in a Cohort of Russian Patients with Familial Hypercholesterolemia Using Targeted Next Generation Sequencing
title_fullStr Verification of Underlying Genetic Cause in a Cohort of Russian Patients with Familial Hypercholesterolemia Using Targeted Next Generation Sequencing
title_full_unstemmed Verification of Underlying Genetic Cause in a Cohort of Russian Patients with Familial Hypercholesterolemia Using Targeted Next Generation Sequencing
title_short Verification of Underlying Genetic Cause in a Cohort of Russian Patients with Familial Hypercholesterolemia Using Targeted Next Generation Sequencing
title_sort verification of underlying genetic cause in a cohort of russian patients with familial hypercholesterolemia using targeted next generation sequencing
topic familial hypercholesterolemia
next generation sequencing
LDLR
Dutch lipid clinic network criteria
cardiovascular risk
url https://www.mdpi.com/2308-3425/7/2/16
work_keys_str_mv AT annaesemenova verificationofunderlyinggeneticcauseinacohortofrussianpatientswithfamilialhypercholesterolemiausingtargetednextgenerationsequencing
AT igorvsergienko verificationofunderlyinggeneticcauseinacohortofrussianpatientswithfamilialhypercholesterolemiausingtargetednextgenerationsequencing
AT diegogarciagiustiniani verificationofunderlyinggeneticcauseinacohortofrussianpatientswithfamilialhypercholesterolemiausingtargetednextgenerationsequencing
AT lorenzomonserrat verificationofunderlyinggeneticcauseinacohortofrussianpatientswithfamilialhypercholesterolemiausingtargetednextgenerationsequencing
AT annabpopova verificationofunderlyinggeneticcauseinacohortofrussianpatientswithfamilialhypercholesterolemiausingtargetednextgenerationsequencing
AT dianannozadze verificationofunderlyinggeneticcauseinacohortofrussianpatientswithfamilialhypercholesterolemiausingtargetednextgenerationsequencing
AT maratvezhov verificationofunderlyinggeneticcauseinacohortofrussianpatientswithfamilialhypercholesterolemiausingtargetednextgenerationsequencing